The possible mechanisms of Aβ(1-40)- or Aβ(1-42)-induced cell death and their rescue factors

Folia Pharmacologica Japonica

Volumn 124, Issue 3, 2004, Pages 135-143

  Nagai, Yasuo ^a   Ogasawara, Aichi ^a   Heese, Klaus ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Alzheimer's disease; Amyloid peptide; BF5 1; Cell death; p60TRP

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BF5 1 PROTEIN; COMPLEMENTARY DNA; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE VIIB; DEXTRO SERINE; GLUTAMIC ACID; INTERLEUKIN 11; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; P18 AMYLOID BETA RESPONSIVE PROTEIN; P60 TRANSCRIPTION REGULATING PROTEIN; PHOSPHATASE; PHOSPHOSERINE PHOSPHATASE; PROTEIN; PROTEIN INHIBITOR; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CELL DEATH; DIFFERENTIAL DISPLAY; DNA LIBRARY; ENZYME SUBUNIT; HUMAN; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARRIER PROTEINS; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-11; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN SUBUNITS; PROTEINS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TAU PROTEINS;

EID: 4644224787     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.124.135     Document Type: Review

References (44)

1. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat. 1995;8:429-431.
2. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, et al. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987;235:880-884.
3. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, et al. The genetic defect causing familiar Alzheimer's disease maps on chromosome 21. Science. 1987;235:885-890.
4. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704-706.
5. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminal of β-amyloid. Nat Genet. 1992;1:345-347.
6. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754-760.
7. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775-778.
8. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
9. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA. 1993;90:1977-1981.
10. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
12. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1995;373:523-527.
13. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlation memory deficits, Aβelevation, and amyloid plaques in transgenic mice. Science. 1996;274:99-102.
14. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, et al. Increased amyloid-β1-42 in brains of mice expressing mutant presenilin 1. Nature. 1996;383:710-713.
15. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939-945.
16. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer disease. Trends Pharmacol Sci. 1991;12:383-388.
17. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Ann Rev Cell Biol. 1994;10:373-403.
18. Younkin SG. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann Neurol. 1995;37:287-288.
19. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, et al. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor dependent, human neuron-like cells. J Neurochem. 2000;75:991-1003.
20. Marcus DL, Strafaci JA, Miller DC, Masia S, Thomas CG, Rosman J, et al. Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease. Neurobiol Aging. 1998;19:393-400.
21. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci. 2001;21:7551-7560.
22. Wei W, Wang X, Kusiak JW. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem. 2002;277:17649-17656.
23. Munoz DG, Feldman H. Cause of Alzheimer's disease. CMAJ. 2000;162:65-72.
24. Heese K, Nakayama T, Hata R, Masumura M, Akatsu H, Li F, et al. Characterizing CGI-94 (comparative gene identification-94) which is down-regulated in the hippocampus of early stage Alzheimer's disease brain. Eur J Neurosci. 2002;15:79-86.
25. Heese K, Nagai Y, Sawada T. Identification of a new synaptic vesicle protein 2B mRNA transcript which is up-regulated in neurons by amyloid beta peptide (Aβ) fragment (1-42). Biochem Biophys Res Commun. 2001;289:924-928.
26. Heese K, Nagai Y, Sawada T. Induction of rat L-phosphoserine phosphatase by amyloid-β (1-42) is inhibited by interleukin-11. Neurosci Lett. 2000;288:37-40.
27. Chouinard ML, Gaitan D, Wood PL. Presence of the N-methyl-D-aspartate- associated glycine receptor agonist D-serine, in human temporal cortex: comparison of normal brain, Parkinson, and Alzheimer tissues. J Neurochem. 1993;61:1561-1564.
28. Espinosa de los Monteros A, Yuan J, McCartney D, Madrid R, Cole R, Kanfer JN, et al. Acceleration of the maturation of oligodendroblasts into oligodendrocytes and enhancement of their myelinogenic properties by a chemically defined medium. Dev Neurosci. 1997;19:297-311.
29. Heese K, Nagai Y, Sawada T. Characterizing rat p 18 amyloid beta (Aβ) responsive protein p18AβrP. Brain Aging. 2002;2:30-38.
30. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. A new generation of protein database search programs. Nucleic Acid Res. 1997;25:3389-3402.
31. Bateman A, Birney E, Durbin R, Eddy SR, Finn RD, Sonnhammer EL. Pfam 3.1:1313 multiple alignments match the majority of proteins. Nucleic Acid Res. 1999;27:260-262.
32. Horton P, Nakai K. A probabilistic classification system for predicting the cellular localization sites of proteins. Intellig Syst Mol Biol. 1996;4:109-115.
33. Horton P, Nakai K. Better prediction of protein cellular localization sites with the k nearest neighbor classifier. Intellig Syst Mol Biol. 1997;5:147-152.
34. Blom N, Gammeltoft S, Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999;294:1351-1362.
35. Pellizzoni L, Baccon J, Rappsilber J, Mann M, Dreyfuss G. Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component. J Biol Chem. 2002;277:7540-7545.
36. Liu Q, Fischer U, Wang F, Dreyfuss G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 1997;90:1013-1021.
37. Fischer U, Liu Q, Dreyfuss G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell. 1997;90:1023-1029.
38. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y. Synergistic antiapoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature. 1997;390:413-417.
39. Fujita M, Nagai Y, Sawada T, Heese K. Identification of rTid-1, the rat homologue of the dorosophila tumor suppressor l (2) tid gene. Mol Cell Biochem. 2004;258:183-189.
40. Heese K, Yamada T, Akatsu H, Yamamoto T, Kosaka K, Nagai Y, et al. Characterization of the new Transcription-Regulator-Protein p60TRP. J Cell Biochem. 2004;91:1030-1042.
41. Nagoshi E, Yoneda Y. Dimerization of sterol regulatory element-binding protein 2 via the helix-loop-helix-leucine zipper domain is a prerequisite for its nuclear localization mediated by importin β. Mol Cell Biol. 2001;21:2779-2789.
42. Vogelsberg-Ragalia V, Schuck T, Trojanowski JQ. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol. 2001;168:402-412.
43. Strack S. Overexpression of the protein phosphatase 2A regulatory subunit Bγ promotes neuronal differentiation by activating the MAP kinase cascade. J Biol Chem. 2002;277:41525-41532.
44. Li X, Scuderi A, Letsou A, Virshup DM. B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol. 2002;22:3674-3684.